Correspondence (reply): In Reply

Por Germing, Ulrich
Publicado em 2014

Reply to “Acute leukemia arising after radioiodine treatment for thyroid cancer” Haematologica 2012;97(8):e28–29

Por Schroeder, Thomas, Germing, Ulrich
Publicado em 2012

Mastering the multitude of monocytoses

Por Germing, Ulrich, Gattermann, Norbert
Publicado no Haematologica (2019)

Myelodysplastic Syndromes: Diagnosis, Prognosis, and Treatment

Por Germing, Ulrich, Kobbe, Guido, Haas, Rainer, Gattermann, Norbert
Publicado em 2013

Mesenchymal stromal cells in myeloid malignancies

Por Schroeder, Thomas, Geyh, Stefanie, Germing, Ulrich, Haas, Rainer
Publicado no Blood Res (2016)

Treatment of Anemia in Transfusion-Dependent and Non-Transfusion-Dependent Lower-Risk MDS: Current and Emerging Strategies

Por Germing, Ulrich, Oliva, Ester N., Hiwase, Devendra, Almeida, Antonio
Publicado no Hemasphere (2019)

Lenalidomide: a brief review of its therapeutic potential in myelodysplastic syndromes

Por Giagounidis, Aristoteles A N, Germing, Ulrich, Haase, Sabine, Aul, Carlo
Publicado em 2007

A patient with glycogen storage disease type Ib presenting with acute myeloid leukemia (AML) bearing monosomy 7 and translocation t(3;8)(q26;q24) after 14 years of treatment with g...

Por Schroeder, Thomas, Hildebrandt, Barbara, Mayatepek, Ertan, Germing, Ulrich, Haas, Rainer
Publicado em 2008

Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: Prevention, Detection, and Treatment

Por Rautenberg, Christina, Germing, Ulrich, Haas, Rainer, Kobbe, Guido, Schroeder, Thomas
Publicado no Int J Mol Sci (2019)

Low RPS14 expression is common in myelodysplastic syndromes without 5q- aberration and defines a subgroup of patients with prolonged survival

Por Czibere, Akos, Bruns, Ingmar, Junge, Bärbel, Singh, Raminder, Kobbe, Guido, Haas, Rainer, Germing, Ulrich
Publicado em 2009

Guidelines for Myelodysplastic Syndromes: Converting Evidence into Action?

Por Kasprzak, Annika, Kaivers, Jennifer, Nachtkamp, Kathrin, Haas, Rainer, Kobbe, Guido, Gattermann, Norbert, Germing, Ulrich
Publicado no Int J Environ Res Public Health (2021)

Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes

Por Giagounidis, Aristoteles, Mufti, Ghulam J., Fenaux, Pierre, Germing, Ulrich, List, Alan, MacBeth, Kyle J.
Publicado em 2013

The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome

Por Zipperer, Esther, Pelz, Daniela, Nachtkamp, Kathrin, Kuendgen, Andrea, Strupp, Corinna, Gattermann, Norbert, Haas, Rainer, Germing, Ulrich
Publicado em 2009

Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients

Por Silzle, Tobias, Blum, Sabine, Schuler, Esther, Kaivers, Jennifer, Rudelius, Martina, Hildebrandt, Barbara, Gattermann, Norbert, Haas, Rainer, Germing, Ulrich
Publicado no Blood Cancer J (2019)

The myelodysplastic syndrome-comorbidity index provides additional prognostic information on patients stratified according to the revised international prognostic scoring system

Por Zipperer, Esther, Tanha, Nina, Strupp, Corinna, Kündgen, Andrea, Nachtkamp, Kathrin, Neukirchen, Judith, Hildebrandt, Barbara, Haas, Rainer, Gattermann, Norbert, Germing, Ulrich
Publicado em 2014

Prognostic impact of peripheral blood WT1-mRNA expression in patients with MDS

Por Rautenberg, Christina, Germing, Ulrich, Pechtel, Sabrina, Lamers, Marius, Fischermanns, Carolin, Jäger, Paul, Geyh, Stefanie, Haas, Rainer, Kobbe, Guido, Schroeder, Thomas
Publicado no Blood Cancer J (2019)

Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromes

Por Hejazi, Maryam, Manser, Angela R., Fröbel, Julia, Kündgen, Andrea, Zhao, Xiaoyi, Schönberg, Kathrin, Germing, Ulrich, Haas, Rainer, Gattermann, Norbert, Uhrberg, Markus
Publicado no Haematologica (2015)

Deferasirox treatment of iron-overloaded chelation-naïve and prechelated patients with myelodysplastic syndromes in medical practice: results from the observational studies eXtend...

Por Gattermann, Norbert, Jarisch, Andrea, Schlag, Rudolf, Blumenstengel, Klaus, Goebeler, Mariele, Groschek, Matthias, Losem, Christoph, Procaccianti, Maria, Junkes, Alexia, Leismann, Oliver, Germing, Ulrich
Publicado em 2012

EASIX for prediction of survival in lower-risk myelodysplastic syndromes

Por Merz, Almuth, Germing, Ulrich, Kobbe, Guido, Kaivers, Jennifer, Jauch, Anna, Radujkovic, Aleksandar, Hummel, Manuela, Benner, Axel, Merz, Maximilian, Dreger, Peter, Luft, Thomas
Publicado no Blood Cancer J (2019)

Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cel...

Por Rautenberg, Christina, Bergmann, Anika, Germing, Ulrich, Fischermanns, Caroline, Pechtel, Sabrina, Kaivers, Jennifer, Jäger, Paul, Schuler, Esther, Haas, Rainer, Kobbe, Guido, Schroeder, Thomas
Publicado no Cancers (Basel) (2020)